Anebulo Total Assets vs Non Current Liabilities Total Analysis

ANEB Stock  USD 2.05  0.05  2.38%   
Anebulo Pharmaceuticals financial indicator trend analysis is way more than just evaluating Anebulo Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anebulo Pharmaceuticals is a good investment. Please check the relationship between Anebulo Pharmaceuticals Total Assets and its Non Current Liabilities Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.

Total Assets vs Non Current Liabilities Total

Total Assets vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anebulo Pharmaceuticals Total Assets account and Non Current Liabilities Total. At this time, the significance of the direction appears to have pay attention.
The correlation between Anebulo Pharmaceuticals' Total Assets and Non Current Liabilities Total is -0.97. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Anebulo Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Anebulo Pharmaceuticals' Total Assets and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Anebulo Pharmaceuticals are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Total Assets i.e., Anebulo Pharmaceuticals' Total Assets and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

-0.97
Relationship DirectionNegative 
Relationship StrengthSignificant

Total Assets

Total assets refers to the total amount of Anebulo Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Anebulo Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Non Current Liabilities Total

Most indicators from Anebulo Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anebulo Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.The current year's Selling General Administrative is expected to grow to about 6.5 M, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.

Anebulo Pharmaceuticals fundamental ratios Correlations

-0.360.920.471.00.98-0.99-0.871.01.0-0.360.890.16-0.97-0.360.290.950.93-0.980.98-0.361.00.870.97-0.360.92
-0.36-0.44-0.56-0.36-0.410.260.69-0.37-0.311.0-0.41-0.980.431.0-0.79-0.04-0.480.42-0.411.0-0.36-0.53-0.41.0-0.55
0.92-0.440.740.930.94-0.93-0.950.930.93-0.441.00.28-0.98-0.440.560.831.0-0.970.94-0.440.920.990.91-0.440.99
0.47-0.560.740.50.52-0.47-0.80.490.48-0.560.760.49-0.68-0.560.730.30.74-0.630.51-0.560.480.820.46-0.560.75
1.0-0.360.930.50.98-0.99-0.881.01.0-0.360.910.17-0.97-0.360.30.940.94-0.990.98-0.361.00.880.97-0.360.93
0.98-0.410.940.520.98-0.97-0.890.980.98-0.410.920.23-0.96-0.410.40.910.95-0.971.0-0.410.980.91.0-0.410.94
-0.990.26-0.93-0.47-0.99-0.970.84-0.99-1.00.26-0.91-0.070.960.26-0.26-0.97-0.930.98-0.970.26-0.99-0.87-0.960.26-0.91
-0.870.69-0.95-0.8-0.88-0.890.84-0.87-0.860.69-0.94-0.540.940.69-0.68-0.69-0.970.93-0.890.69-0.87-0.97-0.860.69-0.98
1.0-0.370.930.491.00.98-0.99-0.871.0-0.370.90.17-0.97-0.370.30.940.94-0.990.98-0.371.00.870.97-0.370.93
1.0-0.310.930.481.00.98-1.0-0.861.0-0.310.90.12-0.97-0.310.280.960.94-0.980.98-0.311.00.870.97-0.310.92
-0.361.0-0.44-0.56-0.36-0.410.260.69-0.37-0.31-0.41-0.980.431.0-0.79-0.04-0.480.42-0.411.0-0.36-0.53-0.41.0-0.55
0.89-0.411.00.760.910.92-0.91-0.940.90.9-0.410.26-0.97-0.410.580.810.99-0.950.92-0.410.890.990.89-0.410.98
0.16-0.980.280.490.170.23-0.07-0.540.170.12-0.980.26-0.25-0.980.81-0.160.32-0.230.23-0.980.160.380.22-0.980.39
-0.970.43-0.98-0.68-0.97-0.960.960.94-0.97-0.970.43-0.97-0.250.43-0.44-0.88-0.991.0-0.960.43-0.97-0.96-0.940.43-0.98
-0.361.0-0.44-0.56-0.36-0.410.260.69-0.37-0.311.0-0.41-0.980.43-0.79-0.04-0.480.42-0.411.0-0.36-0.53-0.41.0-0.55
0.29-0.790.560.730.30.4-0.26-0.680.30.28-0.790.580.81-0.44-0.790.040.55-0.40.4-0.790.280.650.38-0.790.6
0.95-0.040.830.30.940.91-0.97-0.690.940.96-0.040.81-0.16-0.88-0.040.040.83-0.910.91-0.040.940.750.9-0.040.8
0.93-0.481.00.740.940.95-0.93-0.970.940.94-0.480.990.32-0.99-0.480.550.83-0.980.95-0.480.930.990.92-0.481.0
-0.980.42-0.97-0.63-0.99-0.970.980.93-0.99-0.980.42-0.95-0.231.00.42-0.4-0.91-0.98-0.970.42-0.98-0.94-0.950.42-0.97
0.98-0.410.940.510.981.0-0.97-0.890.980.98-0.410.920.23-0.96-0.410.40.910.95-0.97-0.410.980.91.0-0.410.94
-0.361.0-0.44-0.56-0.36-0.410.260.69-0.37-0.311.0-0.41-0.980.431.0-0.79-0.04-0.480.42-0.41-0.36-0.53-0.41.0-0.55
1.0-0.360.920.481.00.98-0.99-0.871.01.0-0.360.890.16-0.97-0.360.280.940.93-0.980.98-0.360.870.97-0.360.92
0.87-0.530.990.820.880.9-0.87-0.970.870.87-0.530.990.38-0.96-0.530.650.750.99-0.940.9-0.530.870.87-0.530.99
0.97-0.40.910.460.971.0-0.96-0.860.970.97-0.40.890.22-0.94-0.40.380.90.92-0.951.0-0.40.970.87-0.40.92
-0.361.0-0.44-0.56-0.36-0.410.260.69-0.37-0.311.0-0.41-0.980.431.0-0.79-0.04-0.480.42-0.411.0-0.36-0.53-0.4-0.55
0.92-0.550.990.750.930.94-0.91-0.980.930.92-0.550.980.39-0.98-0.550.60.81.0-0.970.94-0.550.920.990.92-0.55
Click cells to compare fundamentals

Anebulo Pharmaceuticals Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Anebulo Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anebulo Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anebulo Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anebulo Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.
Note that the Anebulo Pharmaceuticals information on this page should be used as a complementary analysis to other Anebulo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Anebulo Stock analysis

When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Anebulo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anebulo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Return On Assets
(0.58)
Return On Equity
(1.04)
The market value of Anebulo Pharmaceuticals is measured differently than its book value, which is the value of Anebulo that is recorded on the company's balance sheet. Investors also form their own opinion of Anebulo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Anebulo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anebulo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Anebulo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anebulo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anebulo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anebulo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.